Cuidados clínicos del paciente con VIH

Llibre, Josep M.; Fuster‐RuizdeApodaca, María José; Rivero, Antonio; Fernandez, E.

doi:10.1016/s0213-005x(18)30246-5

Cited by 6 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…ART has increased the life expectancy in HIV patients such that it is similar to that of the general population, making HIV a treatable chronic disease from a multidisciplinary approach [ 23 , 31 ].…”

Section: Hivmentioning

confidence: 99%

Antiretroviral Therapy-Induced Dysregulation of Gene Expression and Lipid Metabolism in HIV+ Patients: Beneficial Role of Antioxidant Phytochemicals

Jiménez-Osorio

Jaen-Vega

Fernández-Martínez

et al. 2022

IJMS

View full text Add to dashboard Cite

Human immunodeficiency virus (HIV) infection has continued to be the subject of study since its discovery nearly 40 years ago. Significant advances in research and intake of antiretroviral therapy (ART) have slowed the progression and appearance of the disease symptoms and the incidence of concomitant diseases, which are the leading cause of death in HIV+ persons. However, the prolongation of ART is closely related to chronic degenerative diseases and pathologies caused by oxidative stress (OS) and alterations in lipid metabolism (increased cholesterol levels), both of which are conditions of ART. Therefore, recent research focuses on using natural therapies to diminish the effects of ART and HIV infection: regulating lipid metabolism and reducing OS status. The present review summarizes current information on OS and cholesterol metabolism in HIV+ persons and how the consumption of certain phytochemicals can modulate these. For this purpose, MEDLINE and SCOPUS databases were consulted to identify publications investigating HIV disease and natural therapies and their associated effects.

show abstract

Section: Hivmentioning

confidence: 99%

Antiretroviral Therapy-Induced Dysregulation of Gene Expression and Lipid Metabolism in HIV+ Patients: Beneficial Role of Antioxidant Phytochemicals

Jiménez-Osorio

Jaen-Vega

Fernández-Martínez

et al. 2022

IJMS

View full text Add to dashboard Cite

show abstract

“…Antiretroviral therapy (ART) has significantly improved the prognosis of human immunodeficiency viruses (HIV) infection. Therefore, life expectancy of people living with HIV (PLHIV) has increased [1]. However, this prolongation of sur-vival was associated with raised comorbidities, including cardiovascular complications [2].…”

Section: Introductionmentioning

confidence: 99%

Sub-clinical atherosclerosis in HIV-infected patients: prevalence and risk factors

Abdeljelil,

Kooli,

Bouchahda

et al. 2023

HIV & AIDS Review

View full text Add to dashboard Cite

Introduction: Antiretroviral therapy has significantly improved the prognosis of human immunodeficiency viruses (HIV) infection. Therefore, life expectancy of people living with HIV (PLHIV) has increased. However, this therapy may have some side effects. This study aimed to detect the prevalence of sub-clinical carotid and coronary atherosclerosis among asymptomatic patients living with HIV, free from known cardiovascular diseases, and to identify the factors associated with sub-clinical atherosclerosis. Material and methods:We conducted a cross-sectional prospective study over one year (between July 2018 and June 2019). We included 75 PLHIV, followed-up in the outpatient clinic of the Infectious Diseases Department of the University Hospital Fattouma Bourguiba in Monastir, Tunisia. Cardiovascular assessment, including carotid doppler ultrasonography, electrocardiogram, exercise stress testing, and transthoracic echocardiography was proposed to all study participants. Results:The cardiovascular assessment revealed sub-clinical atherosclerosis in 9 PLHIV (12%): carotid atherosclerosis in 9 cases and coronary artery atherosclerosis in one case. One patient had presented both carotid and coronary atherosclerosis. After multivariate regression analysis, smoking (OR = 2.6; 95% CI: 1.08-6.62%; p = 0.03) and age ≥ 40 years (OR = 2.3; 95% CI: 1.02-5.22%; p = 0.04) were found to be independent risk factors of sub-clinical atherosclerosis in PLHIV. Conclusions:Our study revealed that sub-clinical atherosclerosis was present in 1 of 8 PLHIV. Therefore, screening for atherosclerosis using carotid ultrasound imaging, transthoracic echocardiography, and exercise stress test should be suggested for all PLHIV under 40 years and/or smokers.

show abstract

Lipid profile changes associated with antiretroviral therapies in a real-world cohort

Rotea-Salvo

Giménez‐Arufe

Martínez-Pradeda

et al. 2023

Farmacia Hospitalaria

View full text Add to dashboard Cite

Cuidados clínicos del paciente con VIH

Cited by 6 publications

References 18 publications

Antiretroviral Therapy-Induced Dysregulation of Gene Expression and Lipid Metabolism in HIV+ Patients: Beneficial Role of Antioxidant Phytochemicals

Antiretroviral Therapy-Induced Dysregulation of Gene Expression and Lipid Metabolism in HIV+ Patients: Beneficial Role of Antioxidant Phytochemicals

Sub-clinical atherosclerosis in HIV-infected patients: prevalence and risk factors

Lipid profile changes associated with antiretroviral therapies in a real-world cohort

Contact Info

Product

Resources

About